Bosh sahifaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
28,73 $
Seans yopilganidan keyin:(0,00%)0,00
28,73 $
Yopilgan:14-yan, 16:02:16 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
27,80 $
Kunlik diapazon
27,52 $ - 28,79 $
Yillik diapazon
22,24 $ - 45,99 $
Bozor kapitalizatsiyasi
1,68 mlrd USD
Oʻrtacha hajm
1,47 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 12,88 mln | 43,69% |
Joriy xarajat | 41,27 mln | 7,10% |
Sof foyda | -103,43 mln | -110,91% |
Sof foyda marjasi | -803,05 | -107,59% |
Har bir ulushga tushum | -1,78 | -21,49% |
EBITDA | -115,50 mln | -13,83% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 952,86 mln | -5,17% |
Jami aktivlari | 1,39 mlrd | -22,66% |
Jami passivlari | 101,38 mln | -38,61% |
Umumiy kapital | 1,28 mlrd | — |
Tarqatilgan aksiyalar | 58,31 mln | — |
Narxi/balansdagi bahosi | 1,26 | — |
Aktivlardan daromad | -20,45% | — |
Kapitaldan daromad | -21,27% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -103,43 mln | -110,91% |
Operatsiyalardan naqd pul | -88,15 mln | -4,67% |
Sarmoyadan naqd pul | 95,56 mln | -61,90% |
Moliyadan naqd pul | 4,44 mln | 68,18% |
Naqd pulning sof oʻzgarishi | 11,84 mln | -93,00% |
Boʻsh pul | -56,62 mln | -1 769,96% |
Haqida
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tashkil etilgan
2008
Sayt
Xodimlar soni
487
